東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Implementation of compulsory licensi...

Pang, Hoi Yan.

FindBook

Google Book

Amazon

博客來

Implementation of compulsory licensing provisions under trips in China: Balance between encouraging domestic innovation and wider access to patented drugs.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Implementation of compulsory licensing provisions under trips in China: Balance between encouraging domestic innovation and wider access to patented drugs./
作者:	Pang, Hoi Yan.
面頁冊數:	49 p.
附註:	Source: Masters Abstracts International, Volume: 42-03, page: 0809.
Contained By:	Masters Abstracts International42-03.
標題:	Law. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ84358
ISBN:	0612843580

Implementation of compulsory licensing provisions under trips in China: Balance between encouraging domestic innovation and wider access to patented drugs.
Pang, Hoi Yan.

Implementation of compulsory licensing provisions under trips in China: Balance between encouraging domestic innovation and wider access to patented drugs. - 49 p.

Source: Masters Abstracts International, Volume: 42-03, page: 0809.

Thesis (LL.M.)--University of Toronto (Canada), 2003.

The issue of compulsory licensing is one of the most controversial in the WTO Agreement on Trade-related Aspects of Intellectual Property Rights ("TRIPS Agreement") and remains a topic of intense discussion and debate. However, most of the arguments raised in the debate, both for and against compulsory licensing, are generally from the perspective of either developed countries or developing countries, and ignore the specific situation of larger or more developed, developing countries, such as China and India. This thesis aims to unpack some of the pressing aspects of this debate, with specific application to China. I will argue that the Canadian experience in establishing a compulsory licensing system for drugs is relevant to China. In view of the recent Doha Declaration on the TRIPS Agreement and Public Health ("Doha Declaration"), and certain conflicts between developed and developing countries on its compulsory licensing provisions, it has become less of a risk for China to adopt the Canadian model and be accused of breaching TRIPS Agreement.

ISBN: 0612843580Subjects--Topical Terms:

600858
Law.

Implementation of compulsory licensing provisions under trips in China: Balance between encouraging domestic innovation and wider access to patented drugs.
LDR:02011nmm 2200277 4500 001 1819943
005 20061006144040.5
008 130610s2003 eng d
020 $a 0612843580
035 $a (UnM)AAIMQ84358
035 $a AAIMQ84358
040 $a UnM $c UnM
100 1 $a Pang, Hoi Yan. $3 1909199
245 1 0 $a Implementation of compulsory licensing provisions under trips in China: Balance between encouraging domestic innovation and wider access to patented drugs.
300 $a 49 p.
500 $a Source: Masters Abstracts International, Volume: 42-03, page: 0809.
500 $a Adviser: Jonathan Putnam.
502 $a Thesis (LL.M.)--University of Toronto (Canada), 2003.
520 $a The issue of compulsory licensing is one of the most controversial in the WTO Agreement on Trade-related Aspects of Intellectual Property Rights ("TRIPS Agreement") and remains a topic of intense discussion and debate. However, most of the arguments raised in the debate, both for and against compulsory licensing, are generally from the perspective of either developed countries or developing countries, and ignore the specific situation of larger or more developed, developing countries, such as China and India. This thesis aims to unpack some of the pressing aspects of this debate, with specific application to China. I will argue that the Canadian experience in establishing a compulsory licensing system for drugs is relevant to China. In view of the recent Doha Declaration on the TRIPS Agreement and Public Health ("Doha Declaration"), and certain conflicts between developed and developing countries on its compulsory licensing provisions, it has become less of a risk for China to adopt the Canadian model and be accused of breaching TRIPS Agreement.
590 $a School code: 0779.
650 4 $a Law. $3 600858
650 4 $a Health Sciences, Pharmacy. $3 1017737
690 $a 0398
690 $a 0572
710 2 0 $a University of Toronto (Canada). $3 1017674
773 0 $t Masters Abstracts International $g 42-03.
790 1 0 $a Putnam, Jonathan, $e advisor
790 $a 0779
791 $a LL.M.
792 $a 2003
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=MQ84358